Novo Nordisk A/S (ADR) (NYSE:NVO) soared 0.12% during previous trade, a total of 1.85M shares exchanged hands compared with its average trading volume of 2.78M shares whereas its relative volume is 0.67. The stock has a market capitalization of $70B along with 1.97B outstanding shares. Stock’s intraday price range hit the peak level of $34.73 and touched the lowest level of $34.40.
Most recently Novo Nordisk A/S (ADR) (NYSE:NVO)’s price target was revised on 2/3/17 and according to 1 analyst stock’s price will reach at $36.70 during 52 weeks with standard deviation of 0.00. Stock’s minimum price target estimates has been figured out at $36.70 while the maximum price target forecast is established at $36.70, if we look at the price target with an optimistic approach it has upside potential of 44% from its latest closing price of $34.68.
Historically, if we look at price target revisions, two weeks ago Novo Nordisk A/S (ADR) (NYSE:NVO)’s price target was revised on 2/3/17 by the analysts, however the bullish price estimates of the stock set at $36.70 while the bearish estimates kept at $36.70 over the next one year. Stock’s 52-week target was retained at $36.70, the estimates indicates a standard deviation of 0.00.
While taking an overview of recommendation trends, the stock currently has an average brokerage recommendation of 3.33. ABR value is precisely based on brokerage recommendations, where out of 3 brokerage recommendations 0 rate Novo Nordisk A/S (ADR) (NYSE:NVO) stock a Strong Buy, 0 rate the stocks of the company a Buy, 2 rate Hold, 1 rate Sell and 0 recommend a Strong Sell. Most recently on 10/31/16 the stock of Novo Nordisk A/S (ADR) (NYSE:NVO) downgraded by Citigroup from Buy to Neutral. However previously on 10/31/16 it was downgraded by DNB Markets from Buy to Hold. A research note issued on 10/28/16 the stock was downgraded by BofA/Merrill from Neutral to Underperform.
Novo Nordisk A/S (ADR) (NYSE:NVO) performance over the past one year plunged -32.26% whereas its year to date (YTD) performance indicated a bearish trend of -3.29%. During the last six months the stock slipped -25.77%. Quarterly performance of the company shows optimistic momentum of 3.21% while its last one month trend is negative with -5.48%. Stock’s weekly performance expressed down trend of -2.58%.
The company’s price sits -1.94% below from its 50-day moving average of $25.08 and -19.42% below from the stock’s 200-day moving average which is $38.19. Novo Nordisk A/S (ADR) (NYSE:NVO)’s shares are currently trading -39.44% away from the 52-week high price of $57.26 and +12.27% far from the 52-week low price of $30.89.